首页 正文

Fam-Trastuzumab Deruxtecan in Recurrent Low-Grade Serous Ovarian Carcinoma With CLU/NRG1 Fusion and Low Human Epidermal Growth Factor Receptor 2 Expression: A Case Report

{{output}}